Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2): A follow‐up study

BACKGROUND AND PURPOSE: Population‐based studies suggest severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccines may trigger neurological autoimmunity including immune‐mediated thrombotic thrombocytopenia. Long‐term characterization of cases is warranted to facilitate patient care and...

Descripción completa

Detalles Bibliográficos
Autores principales: Doubrovinskaia, Sofia, Mooshage, Christoph M., Seliger, Corinna, Lorenz, Hanns‐Martin, Nagel, Simon, Lehnert, Pascal, Purrucker, Jan, Wildemann, Brigitte, Bendszus, Martin, Wick, Wolfgang, Schönenberger, Silvia, Kaulen, Leon D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Neuroimmunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874608/
https://www.ncbi.nlm.nih.gov/pubmed/36259114
http://dx.doi.org/10.1111/ene.15602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874608/
https://www.ncbi.nlm.nih.gov/pubmed/36259114
http://dx.doi.org/10.1111/ene.15602

Ejemplares similares